GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Dexcom, Inc. (DXCM) [hlAlert]

Rating:
Buy DXCM
up 1,911.58 %

Dexcom, Inc. (DXCM) rated Buy with price target $9.25 by Canaccord Adams

Posted on: Wednesday,  Aug 6, 2008  11:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy Dexcom, Inc. (NASDAQ: DXCM) on 08/06/2008. Previously Canaccord Adams rated Buy Dexcom, Inc. (NASDAQ: DXCM) on 03/12/2008.,
when the stock price was $4.66. Since then, Dexcom, Inc. has gained 1911.59% as of 01/13/2016's recent price of $93.74.
If you would have followed the previous Canaccord Adams's recommendation on DXCM, you would have gained 1911.58% of your investment in 2863 days.

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/6/2008 11:25 AM Buy
None
6.32 9.25
as of 12/24/2008
1 Week down  -2.62 %
1 Month down  -0.22 %
3 Months up  41.26 %
1 YTD up  61.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2008 11:25 AM Buy
None
4.66 8.75

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy